702 related articles for article (PubMed ID: 27558397)
1. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
[TBL] [Abstract][Full Text] [Related]
2. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium Tuberculosis Infection, Immigration Status, and Diagnostic Discordance: A Comparison of Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube Test Among Immigrants to the U.S.
Wilson FA; Miller TL; Stimpson JP
Public Health Rep; 2016; 131(2):303-10. PubMed ID: 26957665
[TBL] [Abstract][Full Text] [Related]
5. A systematic review on TST and IGRA tests used for diagnosis of LTBI in immigrants.
Campbell JR; Krot J; Elwood K; Cook V; Marra F
Mol Diagn Ther; 2015 Feb; 19(1):9-24. PubMed ID: 25579159
[TBL] [Abstract][Full Text] [Related]
6. Immigrant screening for latent tuberculosis in Norway: a cost-effectiveness analysis.
Haukaas FS; Arnesen TM; Winje BA; Aas E
Eur J Health Econ; 2017 May; 18(4):405-415. PubMed ID: 26970772
[TBL] [Abstract][Full Text] [Related]
7. Risk Assessment of Tuberculosis in Contacts by IFN-γ Release Assays. A Tuberculosis Network European Trials Group Study.
Zellweger JP; Sotgiu G; Block M; Dore S; Altet N; Blunschi R; Bogyi M; Bothamley G; Bothe C; Codecasa L; Costa P; Dominguez J; Duarte R; Fløe A; Fresard I; García-García JM; Goletti D; Halm P; Hellwig D; Henninger E; Heykes-Uden H; Horn L; Kruczak K; Latorre I; Pache G; Rath H; Ringshausen FC; Ruiz AS; Solovic I; Souza-Galvão ML; Widmer U; Witte P; Lange C;
Am J Respir Crit Care Med; 2015 May; 191(10):1176-84. PubMed ID: 25763458
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of interferon-γ release assays and tuberculin skin test in predicting the development of active tuberculosis (UK PREDICT TB): a prospective cohort study.
Abubakar I; Drobniewski F; Southern J; Sitch AJ; Jackson C; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Lynn W; Burgess H; Mann B; Imran A; Sridhar S; Tsou CY; Nikolayevskyy V; Rees-Roberts M; Whitworth H; Kon OM; Haldar P; Kunst H; Anderson S; Hayward A; Watson JM; Milburn H; Lalvani A;
Lancet Infect Dis; 2018 Oct; 18(10):1077-1087. PubMed ID: 30174209
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the QuantiFERON-TB Gold Plus and QuantiFERON-TB Gold In-Tube Interferon Gamma Release Assays in Patients at Risk for Tuberculosis and in Health Care Workers.
Theel ES; Hilgart H; Breen-Lyles M; McCoy K; Flury R; Breeher LE; Wilson J; Sia IG; Whitaker JA; Clain J; Aksamit TR; Escalante P
J Clin Microbiol; 2018 Jul; 56(7):. PubMed ID: 29743310
[TBL] [Abstract][Full Text] [Related]
10. Interferon-γ release assays or tuberculin skin test for detection and management of latent tuberculosis infection: a systematic review and meta-analysis.
Zhou G; Luo Q; Luo S; Teng Z; Ji Z; Yang J; Wang F; Wen S; Ding Z; Li L; Chen T; Abi ME; Jian M; Luo L; Liu A; Bao F
Lancet Infect Dis; 2020 Dec; 20(12):1457-1469. PubMed ID: 32673595
[TBL] [Abstract][Full Text] [Related]
11. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
[TBL] [Abstract][Full Text] [Related]
12. Interferon-γ Release Assays for Tuberculosis Infection Diagnosis in Refugees <5 Years Old.
Wendorf KA; Lowenthal P; Feraud J; Cabanting N; Murto C
Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32994177
[TBL] [Abstract][Full Text] [Related]
13. Absolute risk of tuberculosis among untreated populations with a positive tuberculin skin test or interferon-gamma release assay result: systematic review and meta-analysis.
Campbell JR; Winters N; Menzies D
BMJ; 2020 Mar; 368():m549. PubMed ID: 32156698
[TBL] [Abstract][Full Text] [Related]
14. Community-based evaluation of immigrant tuberculosis screening using interferon γ release assays and tuberculin skin testing: observational study and economic analysis.
Pareek M; Bond M; Shorey J; Seneviratne S; Guy M; White P; Lalvani A; Kon OM
Thorax; 2013 Mar; 68(3):230-9. PubMed ID: 22693179
[TBL] [Abstract][Full Text] [Related]
15. Optimizing tuberculosis screening for immigrants in southern New Brunswick: A pilot study protocol.
Shamputa IC; Nguyen DTK; Higazy D; Abdelhadi A; MacKenzie H; Reddin M; Barker K; Webster D
PLoS One; 2022; 17(11):e0277255. PubMed ID: 36331954
[TBL] [Abstract][Full Text] [Related]
16. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
[TBL] [Abstract][Full Text] [Related]
17. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
Santos JA; Duarte R; Nunes C
Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
[TBL] [Abstract][Full Text] [Related]
18. Combined use of Quantiferon and HBHA-based IGRA supports tuberculosis diagnosis and therapy management in children.
Sali M; Buonsenso D; D'Alfonso P; De Maio F; Ceccarelli M; Battah B; Palucci I; Chiacchio T; Goletti D; Sanguinetti M; Valentini P; Delogu G
J Infect; 2018 Dec; 77(6):526-533. PubMed ID: 30267797
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries.
Hardy AB; Varma R; Collyns T; Moffitt SJ; Mullarkey C; Watson JP
Thorax; 2010 Feb; 65(2):178-80. PubMed ID: 19996345
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
